Predicting Parkinson's disease: Worthwhile but are we there yet?

Practical Neurology

Volumn 6, Issue 5, 2006, Pages 272-277

  Hawkes, Christopher H ^a   Deeb, Jacquie ^a  

^a Essex Neuroscience Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTONOMIC DYSFUNCTION; EDITORIAL; HUMAN; OLFACTORY DISCRIMINATION; PARKINSON DISEASE; PREDICTION; SLEEP DISORDER; SMELLING DISORDER;

EID: 33748994551     PISSN: 14747758     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2006.101238     Document Type: Editorial

References (35)

1. Calne DB, Langston JW. Aetiology of Parkinson's disease. Lancet 1983;2:1457-9.
2. Morrish PK, Parkinson's disease is not a long-latency illness. Mov Disord 1997;12:849-54.
3. Chaudhuri KR, Healy DG, Schapira AH; Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-45.
4. Michell AW, Lewis SJ, Foltynie T, et al. Biomarkers and Parkinson's disease. Brain 2004;127:1693-705.
5. Braak H, Del Tredici K, Rub U. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 2003;24:197-211.
6. Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 1991;114:2283-301
7. Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38:1237-44.
8. Hawkes CH, Shephard BC, Daniel SE. Olfactory dysfunction in Parkinson's disease. J Neurol Neurosurgery Psychiatry 1997;62:436-46
9. Hawkes CH. Olfaction in neurodegenerative disorder. Move Disord 2003;18:364-72.
10. Ponsen MM, Stoffers D, Booij J, et al. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 2004;56:173-81.
11. Ross GW, Petrovitch H, Abbott RD, et al. Association of olfactory dysfunction with risk of future Parkinson's disease. Move Disord 2005;20(Suppl 10)A439 [abstract].
12. Ross GW, Abbott RD, Petrovitch H, et al. Association of olfactory dysfunction with incidental Lewy bodies. Move Disord 2006 (in press).
13. Sommer U, Hummel T, Cormann K, et al. Detection of presymptomatic Parkinson's disease: combining smell tests, transcranial sonography and SPECT. Mov Disord 2004;19:1196-202.
14. Taki J, Yoshita M, Yamada M, et al. Significance of 123I-MIBG scintigraphy as a pathophysiological indicator in the assessment of Parkinson's disease and related disorders: it can be a specific marker for Lewy body disease. Ann Nucl Med 2004;18:453-61.
15. Haapaniemi TH, Pursiainen V, Korpelainen JT, et al. Ambulatory ECG and analysis of heart rate variability in Parkinsons disease. J Neurol Neurosurg Psychiatry 2001;70:305-10.
16. Iwanaga K, Wakabayashi K, Yoshimoto M, et al. Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases. Neurology 1999;52:1269-71.
17. Kaufmann H, Nahm K, Purohit D, et al. Autonomic failure as the initial presentation of Parkinson disease and dementia with Lewy bodies. Neurology 2004;63:1093-5.
18. Pfeiffer RF. Gastrointestinal dysfunction in Parkinson's disease. Lancet Neurol 2003;2:107-16.
19. Braak H, de Vos RA, Bohl J, et al. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 2006,396:67-72.
20. Abbott RD, Petrovitch H, White LR, et al. Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 2001;57:456-62.
21. Adler CH, Thorpy MJ. Sleep issues in Parkinson's disease. Neurology 2005;64(Suppl 3):S12-20.
22. Abbott RD, Ross GW, White LR, et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 2005;65:1442-6.
23. Schenck CH, Bundlie SR, Mahowald MW. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 1996;46:388-93.
24. Eisensehr I, Linke R, Tatsch K, et al. Increased muscle activity during rapid eye movement sleep correlates with decrease of striatal presynaptic dopamine transporters. IPT and IBZM SPECT imaging in subclinical and clinically manifest idiopathic REM sleep behavior disorder, Parkinson's disease, and controls. Sleep 2003;26:507-12.
25. Stiasny-Kolster K, Doerr Y, Moller JC, et al. Combination of 'idiopathic' REM sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 2005;128:126-37.
26. Boeve BF, Silber MH, Parisi JE, et al. Synucleinopathy pathology and REM sleep behavior disorder plus dementia or parkinsonism. Neurology 2003;611:40-5.
27. Abbott RD, Ross GW, White LR, et al. Mid-Life Adiposity and the future risk of Parkinson's disease. Neurology 2002;59:1051-7.
28. Ross GW, Petrovitch H, Abbott RD, et al. Pre-clinical indicators of Parkinson's disease: recent findings from the Honolulu-Asia aging study. Move Disord 2006;21(Suppl 13)AO6 [abstract].
29. Gonera EG, van't Hof M, Berger HJ, et al. Symptoms and duration of the prodromal phase in Parkinson's disease. Mov Disord 1997;12:871-6.
30. de Lau LM, Koudstaal PJ, Hofman A, et al. Subjective complaints precede Parkinson disease: the Rotterdam study. Arch Neurol 2006;63:362-5.
31. Lauterbach EC, Freeman A, Vogel RL. Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson's disease. J Neuropsychiatry Clin Neurosci 2004;16:29-36.
32. Nilsson FM, Kessing LV, Bolwig TG. Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study. Acta Psychiatr Scand 2001;104:380-6
33. Postuma RB, Lang AE, Massicotte-Marquez J, et al. Potential early markers of Parkinson disease in idiopathic REM sleep behavior disorder. Neurology 2006;66:845-51.
34. Schapira AH, Olanow CW. Neuroprotection in Parkinson disease: mysteries, myths, and misconceptions. JAMA 2004;291:358-64.
35. Senior K. UK Biobank launched to mixed reception. Lancet Neurol 2006;5:390.